Transcriptomic Meta-analysis of Multiple Sclerosis and Its Experimental Models
Overview
Authors
Affiliations
Background: Multiple microarray analyses of multiple sclerosis (MS) and its experimental models have been published in the last years.
Objective: Meta-analyses integrate the information from multiple studies and are suggested to be a powerful approach in detecting highly relevant and commonly affected pathways.
Data Sources: ArrayExpress, Gene Expression Omnibus and PubMed databases were screened for microarray gene expression profiling studies of MS and its experimental animal models.
Study Eligibility Criteria: Studies comparing central nervous system (CNS) samples of diseased versus healthy individuals with n >1 per group and publically available raw data were selected.
Material And Methods: Included conditions for re-analysis of differentially expressed genes (DEGs) were MS, myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (EAE) in rats, proteolipid protein-induced EAE in mice, Theiler's murine encephalomyelitis virus-induced demyelinating disease (TMEV-IDD), and a transgenic tumor necrosis factor-overexpressing mouse model (TNFtg). Since solely a single MS raw data set fulfilled the inclusion criteria, a merged list containing the DEGs from two MS-studies was additionally included. Cross-study analysis was performed employing list comparisons of DEGs and alternatively Gene Set Enrichment Analysis (GSEA).
Results: The intersection of DEGs in MS, EAE, TMEV-IDD, and TNFtg contained 12 genes related to macrophage functions. The intersection of EAE, TMEV-IDD and TNFtg comprised 40 DEGs, functionally related to positive regulation of immune response. Over and above, GSEA identified substantially more differentially regulated pathways including coagulation and JAK/STAT-signaling.
Conclusion: A meta-analysis based on a simple comparison of DEGs is over-conservative. In contrast, the more experimental GSEA approach identified both, a priori anticipated as well as promising new candidate pathways.
Sun R, Ma T, Zhao Z, Gao Y, Feng J, Yang X CNS Neurosci Ther. 2024; 30(11):e70111.
PMID: 39548665 PMC: 11567942. DOI: 10.1111/cns.70111.
You Y, Muraoka S, Jedrychowski M, Hu J, McQuade A, Young-Pearse T J Extracell Vesicles. 2022; 11(1):e12183.
PMID: 35029059 PMC: 8758831. DOI: 10.1002/jev2.12183.
Revisiting the Pathoetiology of Multiple Sclerosis: Has the Tail Been Wagging the Mouse?.
Sen M, Almuslehi M, Shortland P, Coorssen J, Mahns D Front Immunol. 2020; 11:572186.
PMID: 33117365 PMC: 7553052. DOI: 10.3389/fimmu.2020.572186.
A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis.
Ramesh A, Schubert R, Greenfield A, Dandekar R, Loudermilk R, Sabatino Jr J Proc Natl Acad Sci U S A. 2020; 117(37):22932-22943.
PMID: 32859762 PMC: 7502747. DOI: 10.1073/pnas.2008523117.
Hansmann F, Zhang N, Herder V, Leitzen E, Baumgartner W Int J Mol Sci. 2019; 20(7).
PMID: 30959793 PMC: 6480673. DOI: 10.3390/ijms20071702.